Acute Hepatic Porphyria (AHP)
View the latest scientific data presented at congress events in the past 2 years and discover peer-reviewed publications related to AHP.
The information on this page pertains to select congress and publication resources. It is not intended to serve as a comprehensive list of all congress and publications resources.
Congresses
Acute Hepatic Porphyria (AHP)
Digestive Disease Week (DDW) 2026
Acute Hepatic Porphyria (AHP)
Thrombosis and Hemostasis Summit of North America (THSNA) 2026
Acute Hepatic Porphyria (AHP)
American Association for the Study of Liver Diseases (AASLD) 2025
Acute Hepatic Porphyria (AHP)
International Porphyrias Symposium (IPS) 2025
Acute Hepatic Porphyria (AHP)
International Congress of Inborn Errors Metabolism (ICIEM) 2025
Acute Hepatic Porphyria (AHP)
Digestive Disease Week (DDW) 2025
Publications
Acute Hepatic Porphyria (AHP)
Patient experience with acute hepatic porphyria before and after long-term givosiran treatment in a qualitative interview study
Molecular Genetics and Metabolism Reports
Acute Hepatic Porphyria (AHP)
Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1/2, 48-month open-label extension study
Orphanet Journal of Rare Diseases
Acute Hepatic Porphyria (AHP)
High disease burden and healthcare resource usage in patients with acute porphyria—A population-based analysis
Liver International
Acute Hepatic Porphyria (AHP)
A randomized, placebo-controlled study of givosiran in patients with acute hepatic porphyrias (ENVISION): Final (36-month) analysis of the Taiwan Cohort
Journal of the Formosan Medical Association
Acute Hepatic Porphyria (AHP)
Elevated homocysteine is negatively correlated with plasma cystathionine β ‐synthase activity in givosiran‐treated patients
Journal of Inherited Metabolic Disease Reports
Acute Hepatic Porphyria (AHP)
Clinical features of acute attacks, chronic symptoms, and long-term complications among patients with acute hepatic porphyria in Japan: a real-world claims database study
Orphanet Journal of Rare Diseases
